1. Home
  2. EHTH vs SER Comparison

EHTH vs SER Comparison

Compare EHTH & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

N/A

Current Price

$1.24

Market Cap

46.0M

Sector

Finance

ML Signal

N/A

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

N/A

Current Price

$2.74

Market Cap

42.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EHTH
SER
Founded
1997
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
42.0M
IPO Year
2006
2024

Fundamental Metrics

Financial Performance
Metric
EHTH
SER
Price
$1.24
$2.74
Analyst Decision
Hold
Strong Buy
Analyst Count
3
1
Target Price
$3.33
$15.00
AVG Volume (30 Days)
219.7K
54.5K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
$130,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
132.14
52 Week Low
$1.19
$1.22
52 Week High
$5.89
$7.92

Technical Indicators

Market Signals
Indicator
EHTH
SER
Relative Strength Index (RSI) 40.89 63.48
Support Level $1.21 $1.69
Resistance Level $1.55 $3.16
Average True Range (ATR) 0.08 0.21
MACD 0.00 0.01
Stochastic Oscillator 14.75 78.75

Price Performance

Historical Comparison
EHTH
SER

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: